Telomerase activity in human cancer

Current Opinion in Oncology

Volumn 8, Issue 1, 1996, Pages 66-71

  Shay, Jerry W ^a   Wright, Woodring E ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

RIBONUCLEOPROTEIN; TELOMERASE;

CANCER DIAGNOSIS; CANCER GROWTH; CANCER REGRESSION; CELL AGING; CELL DIVISION; ENZYME ACTIVITY; ENZYME INHIBITION; HUMAN; METASTASIS; PRIORITY JOURNAL; REVIEW; SOMATIC MUTATION; STEM CELL; TELOMERE; VIRUS ONCOGENE;

EID: 0029991014     PISSN: 10408746     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001622-199601000-00012     Document Type: Review

References (49)

1. Shay JW, Werbin H, Wright WE: Telomere shortening may contribute to aging and cancer: a perspective. Mol Cell Diff 1994, 2:1-18.
2. Wright WE, Shay JW: Time, telomeres and tumours: is cellular senescence more than an anticancer mechanism? Trends Cell Biol 1995, 5:293-297. This paper presents an evolutionary rationale for why cellular senescence may not only be an anticancer mechanism but may also be the cause of many of the degenerative changes of aging.
3. Shay JW, Werbin H, Wright WE: You haven't heard the end of it: telomere loss may link human aging and cancer. Canadian J Aging 1995, 142:511-524.
4. Harley CB: Telomeres and aging: fact, fancy, and the future. J NIH Res 1995, 7:64-68.
5. Harley CB, Villeponteau B: Telomeres and telomerase in aging and cancer. Curr Opin Genet Dev 1995, 5:249-255.
6. Shippen DE: Telomeres and telomerases. Curr Opin Genet Dev 1993, 3:759-763.
7. Palladino F, Gasser S: Telomere maintenance and gene repression: a common end? Curr Opin Cell Biol 1994, 6:373-379.
8. Greider C: Mammalian telomere dynamics: healing, fragmentation shortening and stabilization. Curr Opin Genet Dev 1994, 4:203-211.
9. Rhyu MS: Telomeres, telomerase, and immortality. J Natl Cancer Inst 1995, 87:884-894.
10. Morin GB: Is telomerase a universal cancer target? J Natl Cancer Inst 1995, 87:859-861.
11. Bacchetti S, Counter CM: Telomeres and telomerase in human cancer. Int J Oncol 1995, 7:423-432.
12. Skolnick A: Cancer cell's immortality may prove their undoing. JAMA 1995, 273:1247-1248.
13. Seachrist L: Telomeres draw a crowd at Toronto cancer meeting. Science 1995, 268:29-30.
14. Haber DA: Telomeres, cancer, and immortality. N Engl J Med 1995, 332:955-956.
15. Steel M: Telomerase that shapes our ends. Lancet 1995, 345:935-936.
16. Kipling D: Telomerase: immortality enzyme or oncogene? Nat Genet 1995, 9:104-106.
17. De Lange T: Activation of telomerase in a human tumor. Proc Natl Acad Sci U S A 1994, 91:2882-2885.
18. Blackburn EH: Telomeres: no end in sight. Cell 1994, 77:621-623.
19. Shay JW, Brasiskyte D, Ouellete M, Piatyszek MA, Werbin H, Ying Y, Wright WE: Methods for Analysis of Telomerase and Telomeres. In Methods in Molecular Genetics. Edited by Adolph KW. San Diego: Academic Press; 1994: 263-280. A detailed methodology for the analysis of telomere length and detailed protocols to assay for telomerase activity using the primer extension assay.
20. Counter CM, Hirte HW, Bacchetti S, Harley CB: Telomerase activity in human ovarian carcinoma. Proc Natl Acad Sci U S A 1994, 91:2900-2904. The first report of telomerase activity in human cancer using the primer extension assay.
21. Nilsson P, Mehle C, Roos R, Roos G: Telomerase activity in vivo in human malignant hematopoietic cells. Oncogene 1994, 9:3043-3048.
22. Kim NW, Piatyszek MA, Prowse KR, Harley CB, West MD, Ho PLC, Coviello GM, Wright WE, Weinrich SL, Shay JW: Specific association of human telomerase activity with immortal cells and cancer. Science 1994, 266:2011-2015. Description of telomere repeat amplification protocol, a highly sensitive and reproducible telomerase assay. This paper also includes a broad survey of telomerase activity in human tumors and cell lines.
23. Piatyszek MA, Kim NW, Weinrich SL, Hiyama K, Hiyama E, Wright WE, Shay JW: Detection of telomerase activity in human cells and tumors by a telomeric repeat amplification protocol (TRAP). Methods Cell Sci 1995, 17:1-15. A detailed methodology to conduct the telomeric repeat amplification protocol assay for human tumor tissues.
24. Hiyama E, Hiyama K, Yokoyama T, Matsuura Y, Piatyszek MA, Shay JW: Correlating telomerase activity levels with human neuroblastoma outcomes. Nature Med 1995, 1:249-257. First comprehensive analysis of telomerase activity in a specific type of cancer. Documents that telomerase activity correlates with severity of the disease. Most patients with metastatic disease with low or undetectable telomerase activity went into remission. Also reports on the first evidence that telomerase activity may be required for the sustained growth of tumor cells.
25. Hiyama E, Yokoyama T, Tatsumoto N, Hiyama K, Imamura Y, Murakami Y, Kodama T, Piatyszek MA, Shay JW, Matsuura Y: Telomerase activity in gastric cancer. Cancer Res 1995, 55:3258-3262. In this paper, patients with gastric cancer with telomerase activity had significantly shorter survival time than those with telomerase-negative cancers.
26. Hiyama K, Hiyama E, Ishioka S, Yamakido M, Inai K, Gazdar AF, Piatyszek MA, Shay JW: Telomerase activity in small-cell and non-small-cell lung cancers. J Natl Cancer Inst 1995, 87:895-902. Although most patients with lung cancer had detectable telomerase activity, some did not. This paper supports the idea that some cancers may be mortal tumors. First detection of telomerase activity using pleural effusions, indicating that simple diagnostic tests for telomerase (eg, bronchial or perhaps bladder washes) may be useful.
27. Tahara H, Nakanishi T, Kitamoto M, Nakashio R, Shay JW, Tahara E, Kajiyama G, Ide T: Telomerase activity in human liver tissues: comparison between chronic liver disease and hepatocellular carcinomas. Cancer Res 1995, 55:2734-2736.
28. Chadeneau C, Hay K, Hirte HW, Galligner S, Bacchetti S: Telomerase activity associated with acquisition of malignancy in human colorectal cancer. Cancer Res 1995, 55:2533-2536.
29. Mehle C, Piatyszek MA, Ljungberg B, Shay JW, Roos G: Telomerase activity in human renal cell carcinoma. Oncogene 1996, in press.
30. Tahara H, Kuniyasu H, Yasui W, Yokozaki H, Shay JW, Ide T, Tahara E: Telomerase activity in gastric and colorectal carcinomas correlates well with malignant progression. Clin Cancer Res 1996, in press.
31. Harley CB, Kim NW, Prowse KR, Weinrich SL, Hirsch K, West MD, Bacchetti S, Counter CM, Hirte HW, Greider CW, Wright WE, Shay JW: "Cell immortality, telomerase and cancer." Cold Spring Harbor Symp Quant Biol 1995, 59:307-315. A theoretical model demonstrating the effect of telomerase inhibition on tumor growth.
32. Counter CM, Gupta J, Harley CB, Leber B, Bacchetti S: Telomerase activity in normal leukocytes and in hematologic malignancies. Blood 1995, 85:2315-2320.
33. Broccoli D, Young JW, De Lange T: Telomerase activity in normal and malignant hematopoietic cells. Proc Natl Acad Sci USA 1996, in press.
34. Hiyama K, Hirai Y, Kyoizumi S, Akiyman M, Hiyama E, Piatyszek MA, Shay JW, Ishioka S, Yamakido M: Activation of telomerase in human lymphocytes and hematopoietic progenitor cells. J Immunol 1995, 155:3711-3715. This paper demonstrates that very low levels of telomerase activity are present in bone marrow stem cells, and that stimulated cells have increased activity. It also demonstrates that peripheral blood mononuclear cells (B and T cells) have low telomerase activity that increases with in vitro stimulation. First report that telomerase activity in normal peripheral blood mononuclear cells decreases with increasing age.
35. Sommerfeld H, Meeker AK, Posadas EM, Coffey DS: Frontiers in prostate cancer: telomeres and chaos. Cancer 1995, 75:2027-2035.
36. Wright WE, Shay JW, Piatyszek MA: Modification of a telomeric repeat amplification protocol (TRAP) results in increased reliability, linearity and sensitivity. Nucleic Acids Res 1995, 23:3794-3795. Details a modification of the TRAP assay to include an internal standard to permit quantitative statements about telomerase activity levels and to permit comparison between gels. Also describes a procedure for detecting telomerase activity in single cells.
37. Wright WE, Piatyszek MA, Rainey WE, Byrd W, Shay JW: Telomerase activity in human germline and embryonic tissues and cells. Dev Genet 1996, in press.
38. Prowse KR, Greider CW: Development and tissue-specific regulation of mouse telomerase and telomere length. Proc Natl Acad Sci U S A 1995, 92:4818-4822.
39. Vaziri H, Dragowska W, Allsopp RC, Thomas TE, Harley CB, Lansdorp PM: Evidence for a mitotic clock in human hematopoletic stem cells: loss of telomeric DNA with age. Proc Natl Acad Sci U S A 1994, 91:9857-9860.
40. Lansdorp PM: Telomere length and proliferation potential of hematopoietic stem cells. J Cell Sci 1995, 108:1-6.
41. Chui P, Dragowski V, Kim NW, Veziri H, Thomas TE, Harley CB, Landsdorf PM: Telomerase activity in hematopoletic progenitor cell extracts from adult bone marrow. Blood 1996, in press.
42. Miller BA, Feurer EJ, Hankey BF: Recent incidence trends for breast cancer in women and relevance of early detection: an update. Cancer 1993, 43:27-41.
43. Quiet CA, Ferguson DJ, Weichelselbaum RR, Hellman S: Natural history of node-negative breast cancers: a study of 826 patients with long-term follow-up. J Clin Oncol 1995, 12:1144-1151.
44. Feng J, Funk WD, Wang S-S, Weinrich SL, Avilion AA, Chiu C-P, Adams RR, Chang E, Allsopp RC, Yu J, Le S, West MD, Harley CB, Andrews WH, Greider CW, Villeponteau B: The RNA component of human telomerase. Science 1995, 269:1236-1241. Describes the cloning of the RNA component of human telomerase. The template region of human telomerase encompasses 11 nucleotides complementary to the human TTAGGG telomeric ends. Germline and tumor cell lines express more human telomerase RNA than normal somatic cells and tissues. Human cell lines that express a mutant form of telomerase generate the predicted mutant telomerase activity. HeLa cells transfected with an antisense human telomerase lose telomeric DNA and eventually begin to die.
45. Blasco MA, Funk W, Villeponteau B, Greider CW: Functional characterization and developmental regulation of mouse telomerase RNA. Science 1995, 269:1267-1270. Describes the cloning of the mouse telomerase RNA component. The template region of mouse telomerase RNA is shorter than the human telomerase template region. Telomerase RNA levels increase approximately 18-fold in the immortal cells derived from primary mouse fibroblasts. The RNA is detected in all newborn mouse tissues, but is downregulated during postnatal development. The presence of telomerase RNA correlates with the presence of telomerase activity in adult mouse tissues.
46. Ohmura H, Tahara H, Suzuki M, Ide T, Shimizu M, Yoshida MA, Tahara E, Shay JW, Barrett JC, Oshimura M: Restoration of the cellular senescence program and repression of telomerase by chromosome 3. Jpn J Cancer Res 1995, 86:899-904.
47. Murnane JP, Sabatier L, Marder BA, Morgan WF: Telomere dynamics in an immortal human cell line. EMBO J 1994, 13:4953-4962.
48. Bryan TM, Englezou A, Gupta J, Bacchetti S, Reddel RR: Telomere elongation in immortal human cells without detectable telomerase activity. EMBO J 1996, in press.
49. Collins K, Kobayashi R, Greider CW: Purification of Tetrahymena telomerase and cloning of genes encoding the two protein components of the enzyme. Cell 1995, 81:677-686.